India passes key vaccination milestone after relaxations




  • In US
  • 2021-03-05 06:39:05Z
  • By Reuters
 

NEW DELHI (Reuters) - India administered 1.4 million vaccine doses in the past 24 hours, health ministry data showed on Friday, the highest in a day since the campaign began in mid-January as the government moves to address initial hiccups.

The country of 1.35 billion people still has to nearly double its current rate of vaccination to meet its target of covering 300 million people by August. The two vaccines in use in India need to be administered in two doses, four to six weeks apart.

India has so far given 18 million doses to about 15 million people.

The vaccination pace increased this week after Prime Minister Narendra Modi kicked off an expansion of the drive to include the elderly and those aged 45-59 suffering from medical conditions.

The government has also roped in many private hospitals, allowing them to run vaccinations throughout the day and assuring there is no shortage of shots in the world's biggest vaccine-making country.

Unlike earlier when health and frontline workers had to get their shots in assigned vaccination centres, people are now free to choose their site.

Modi, 70, on Monday opted for Bharat Biotech's government-backed vaccine COVAXIN, although most people are getting the shot licensed from AstraZeneca. The next vaccines in line for regulatory approval are Russia's Sputnik-V and Cadila Healthcare's ZyCoV-D.

India reported 16,838 new COVID-19 cases in the past 24 hours, taking the total to 11.2 million, only behind the U.S. tally of about 29.5 million. Deaths rose by 113 to 157,548.

(Reporting by Krishna N. Das and Philip George; Editing by Stephen Coates)

COMMENTS

More Related News

Russia expects India to produce 50 million doses of Sputnik V each month this summer
Russia expects India to produce 50 million doses of Sputnik V each month this summer
  • US
  • 2021-04-13 14:15:41Z

Russia is expecting India to initially be making 50 million doses of its Sputnik V COVID-19 vaccine each month this summer, Kirill Dmitriev, head of Russian ...

White House says J&J pause will not have "significant impact" on vaccination plan
White House says J&J pause will not have "significant impact" on vaccination plan

The White House said Tuesday that the FDA's recommendation that the U.S. pause use of Johnson & Johnson's COVID-19 vaccine "will not have a significant...

India to approve coronavirus shots green-lit by WHO, others
India to approve coronavirus shots green-lit by WHO, others
  • US
  • 2021-04-13 08:36:33Z

India said Tuesday that it will approve the use of all coronavirus vaccines that have been given an emergency nod by the World Health Organization or...

Cipla doubles remdesivir production to meet
Cipla doubles remdesivir production to meet 'unprecedented' demand

India's Cipla Ltd has doubled production of COVID-19 medication remdesivir to help meet "unprecedented demand" as the country battles a massive second wave...

India
India's Cipla doubles remdesivir production to meet 'unprecedented' demand
  • US
  • 2021-04-13 08:20:03Z

India's Cipla Ltd has doubled production of COVID-19 medication remdesivir to help meet "unprecedented demand" as the country battles a massive second wave...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: US